DOYLE MITTIE (Chief Medical Officer) received a stock award from AVALO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/26/2026ACC: 0001918845-26-000014
Officer· Chief Medical Officer
Since Feb 2026
+43.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
43.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+43.50K
Price / share
—
Trade value
—
% of position
1201.0%
5/21/2026
3.62K→47.12K
Total
Net shares
+43.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/21/2026 | A · Award | +43.50K | — | — | 1201.0% | 3.62K | 47.12K |
| Total | +43.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported